Levofloxacin

  • High‑purity pharmaceutical‑grade API, meets USP, EP and CP pharmacopoeia standards, strict impurity control

  • Broad‑spectrum bactericidal activity against Gram‑positive and Gram‑negative bacteria for respiratory, urinary and skin‑tissue infection formulations

  • Good solubility and high bioavailability, suitable for tablets, capsules and injection dosage processing

  • Stable physical‑chemical property, long shelf‑life, convenient for pharmaceutical production and storage

  • Available in multiple salt forms: hemihydrate, hydrochloride, lactate for different formulation demands

WhatsApp

Product Description

Levofloxacin is a third‑generation fluoroquinolone broad‑spectrum antibacterial pharmaceutical API. It inhibits bacterial DNA replication for effective control of Gram‑positive and Gram‑negative bacteria. Multiple salt forms are available for tablets, capsules and injections. Compliant with USP, EP, CP standards under GMP production, strict impurity control ensures stable quality. Complete documents, stable bulk supply and customized packaging are offered for global pharmaceutical buyers.

Basic Info.

Model NO.

Raw materials

Quality

Refined

Color

White

CAS No.

100986-85

Sample

Available

Documents

MOA, MSDS, COA, ROS, HNMR, CNMR, MS

Origin

China

Application

  1. Respiratory Infections: Levofloxacin is prescribed for the treatment of respiratory infections such as pneumonia, bronchitis, and sinusitis caused by susceptible bacteria.

  2. Urinary Tract Infections: It is effective in treating uncomplicated and complicated urinary tract infections, including cystitis and pyelonephritis.

  3. Skin and Soft Tissue Infections: Levofloxacin is also used for the management of skin and soft tissue infections caused by bacteria.

Online Consultation

Please fill out the form below and we will contact you as soon as possible

WhatsApp